Format

Send to

Choose Destination
Fertil Steril. 1998 Dec;70(6):1044-8.

Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization.

Author information

1
Department of Obstetrics and Gynecology, Niigata University School of Medicine, Japan.

Abstract

OBJECTIVE:

To evaluate the effect of prednisolone plus low-dose aspirin (PSL/LDA) in women with autoimmune conditions who were enrolled in an IVF-ET program.

DESIGN:

A retrospective clinical study.

SETTING:

In vitro fertilization unit, Niigata University Hospital, Niigata, Japan.

PATIENT(S):

Three hundred seven women who underwent IVF-ET between January 1996 and December 1997.

INTERVENTION(S):

Prednisolone (10 mg/d) and aspirin (81 mg/d) were administered to the women with autoantibodies who chose to participate.

MAIN OUTCOME MEASURE(S):

Pregnancy and implantation rates with IVF-ET.

RESULT(S):

Women undergoing IVF who had positive antinuclear antibodies, with or without antiphospholipid antibodies, had significantly lower pregnancy and implantation rates than did women without autoantibodies (14.8% versus 21.7% and 6.8% versus 10.4%, respectively). The administration of PSL/LDA to women with antinuclear antibodies significantly improved the outcome of IVF-ET (40.6% pregnancy rate and 20.3% implantation rate).

CONCLUSION(S):

A high proportion of women who are undergoing IVF-ET have autoantibodies, which are associated with poor IVF outcomes. The administration of PSL/LDA to these women may improve their implantation rate.

PMID:
9848293
DOI:
10.1016/s0015-0282(98)00343-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center